Albemarle Corporation (ALB) Q2 2025 10-Q Quarterly Report
Filed: Aug 4, 2025Period ending Jun 30, 2025
Health Care
Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR Albemarle Corporation (ALB) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 4, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Albemarle Corporation Q2 2025 10-Q Analysis
Risk Factors
- • No material changes in risk factors from the most recent 10-K filing
- • Continued exposure to market volatility impacting lithium demand and pricing
Albemarle Corporation Q2 2025 Quarterly FinancialsXBRL
Revenue
$1.3B
▼ -7.0% YoY▲ +23.5% QoQ
Net Income
$23M
▲ +112.2% YoY▼ -44.6% QoQ
Gross Margin
14.8%
▲ +29bp QoQ
Operating Margin
3.6%
▲ +3801bp YoY▲ +174bp QoQ
Net Margin
1.7%
▲ +1488bp YoY▼ -212bp QoQ
EPS (Diluted)
$-0.16
▲ +91.8% YoY
Operating Cash Flow
-$7M
▼ -102.0% YoY▼ -101.3% QoQ
Source: XBRL data from Albemarle Corporation Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Albemarle Corporation Quarterly Reports
Get deeper insights on Albemarle Corporation
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.